Figure 2个  Table 1个
    • Participant no. Age (year of birth) Gender Seroprevalence of anti-DENV nAb Positive serotype of DENV
      Titers of anti-DENV nAb
      DENV1 DENV2 DENV3 DENV4
      3052 20(1999) Female < 1:10 < 1:10 1:20 < 1:10 DENV3
      3072 20(1999) Female 1:40 < 1:10 < 1:10 < 1:10 DENV1
      3099 20(1999) Male < 1:10 1:20 < 1:10 < 1:10 DENV2
      3103 20(1999) Female 1:20 < 1:10 < 1:10 < 1:10 DENV1
      3107 20(1999) Female 1:160 < 1:10 1:10 < 1:10 DENV1, DENV3
      3150 20(1999) Male < 1:10 1:10 1:20 < 1:10 DENV2, DENV3
      3461 20(1999) Female < 1:10 < 1:10 < 1:10 < 1:10 None
      3482 20(1999) Female 1:10 1:20 < 1:10 < 1:10 DENV1, DENV2
      3505 20(1999) Female < 1:10 < 1:10 1:20 < 1:10 DENV3
      3591 20(1999) Male < 1:10 1:20 1:20 < 1:10 DENV2, DENV3
      3616 21(1998) Male < 1:10 1:20 1:20 < 1:10 DENV2, DENV3
      3631 20(1999) Female 1:20 < 1:10 1:10 < 1:10 DENV1, DENV3
      4404 20(1999) Female 1:20 1:10 < 1:10 1:10 DENV1, DENV2, DENV4
      4468 21(1998) Female 1:20 < 1:10 < 1:10 < 1:10 DENV1

      Table 1.  Seroprevalence of anti-DENV nAb among all anti-DENV IgG antibody positive participants (n = 14).